presented by Elise K. Cantu, PT, DPT, OCS
Financial: Elise Cantu is the director of The Onco PT, LLC, and Fort Worth Cancer Care, PLLC. She is also a consultant for Brylan’s Feat Foundation and a contractor for Pediatric Lymphedema Alliance.
Nonfinancial: Elise Cantu has no competing nonfinancial interests or relationships with regard to the content presented in this course.
Satisfactory completion requirements: All disciplines must complete learning assessments to be awarded credit, no minimum score required unless otherwise specified within the course.
MedBridge is committed to accessibility for all of our subscribers. If you are in need of a disability-related accommodation, please contact [email protected]. We will process requests for reasonable accommodation and will provide reasonable accommodations where appropriate, in a prompt and efficient manner.
Elise K. Cantu, PT, DPT, OCS
Dr. Elise K. Cantu has dedicated her career to helping others live better beyond a cancer diagnosis. Dr. Cantu is also the director of Fort Worth Cancer Care, a private oncology rehab clinic in Fort Worth, Texas. She is also the host of TheOncoPT Podcast, where she educates other physical therapists on how treat people…
Read full bioEmail could not be subscribed.
Thank you for signing up!
Thank you!
1. Immunotherapy Basics
Immunotherapy is quickly emerging as a more common cancer treatment. Thus, rehab professionals must understand the basics of immunotherapy, how it works, and why it is used in cancer treatment.
2. How Immunotherapy Affects the Body
Immunotherapy comprises many different treatment interventions, each with their own mechanism of action and purpose. While immunotherapies are better at specifically targeting cancer cells, they can still cause significant side effects. Rehab professionals must understand signs and symptoms of immunotherapy toxicity in patients.
3. How Immunotherapy Affects Rehab
Due to the potentially life-threatening toxicities associated with immunotherapy, clinicians must be able to recognize signs and symptoms of immunotherapy toxicity. After the conclusion of this chapter, clinicians will recognize how a person’s functional mobility can be affected with immunotherapy and how to modify rehab for the person treated with immunotherapy.
More Courses in this Series
Email could not be subscribed.
Thank you for signing up!